Edition:
United Kingdom

Co-Diagnostics Inc (CODX.OQ)

CODX.OQ on NASDAQ Stock Exchange Capital Market

2.01USD
20 Apr 2018
Change (% chg)

$0.08 (+4.15%)
Prev Close
$1.93
Open
$1.92
Day's High
$2.01
Day's Low
$1.92
Volume
1,209
Avg. Vol
7,576
52-wk High
$6.85
52-wk Low
$1.45

Chart for

About

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $67.69
Shares Outstanding(Mil.): 11.92
Dividend: --
Yield (%): --

Financials

  CODX.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -- -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Co-Diagnostics Announces Construction Update At Facility In India

* CO-DIAGNOSTICS, INC. ANNOUNCES CONSTRUCTION UPDATE AT JV MANUFACTURING FACILITY IN INDIA

22 Mar 2018

BRIEF-Co-Diagnostics Inc Announces Positive Results From Co-Primers Technology In Multiplex Tests For SNP Detection

* CO-DIAGNOSTICS INC ANNOUNCES POSITIVE RESULTS FROM CO-PRIMERS™ TECHNOLOGY IN MULTIPLEX TESTS FOR SNP DETECTION Source text for Eikon: Further company coverage:

28 Feb 2018

BRIEF-Co-Diagnostics Enters Into Lease For Upgraded Laboratory Facility In Salt Lake City

* CO-DIAGNOSTICS - ENTERS INTO LEASE FOR BIOLOGICAL SAFETY LEVEL 2 LABORATORY FACILITY IN SALT LAKE CITY, UTAH

19 Dec 2017

Earnings vs. Estimates

No consensus analysis data available.